DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nardil (Phenelzine Sulfate) - Published Studies

 
 



Nardil Related Published Studies

Well-designed clinical trials related to Nardil (Phenelzine)

A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder. [2010.03]

A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder. [2010]

Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial. [2007.08]

Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients. [2004.11]

Rapid tryptophan depletion reverses phenelzine-induced suppression of REM sleep. [2003.03]

Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. [1999.05]

Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. [1998.12]

Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. [1997.09]

Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission. [1997.01]

Fluoxetine versus phenelzine in atypical depression. [1996.11.15]

Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome. [1996.04]

A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives. [1994.01]

Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine. [1993.12]

Chronic depression: response to placebo, imipramine, and phenelzine. [1993.12]

Efficacy of phenelzine and haloperidol in borderline personality disorder. [1993.05]

A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression. [1993.01]

Haloperidol vs. phenelzine in continuation therapy of borderline disorder. [1993]

Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial. [1992.11]

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison. [1992.04]

Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. [1991.06]

Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design. [1991.04]

Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study. [1991]

Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication. [1990.10]

Phenelzine and atenolol in social phobia. [1990]

Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo. [1989.12]

Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression. [1989.09]

A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. [1989.09]

A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. [1988.10]

The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients. [1988.08]

Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol. [1988.07]

Well-designed clinical trials possibly related to Nardil (Phenelzine)

Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials. [2011]

Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline. [2010.12]

Treatment options for bipolar depression: a systematic review of randomized, controlled trials. [2010.10]

Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline. [2010]

Validity of sudden gains in acute phase treatment of depression. [2005.02]

Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy. [1996]

Self selection and sample selection in a treatment study of social phobia. [1995.03]

Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant. [1994.08]

Duration of antidepressant trials: clinical and research implications. [1994.02]

Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. [1993.09]

[Impact of personality factors in depression] [1993.08]

Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies. [1993]

Predictive value of symptoms of atypical depression for differential drug treatment outcome. [1992.06]

Can mildly depressed outpatients with atypical depression benefit from antidepressants? [1992.05]

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. [1991.10]

Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants. [1991.09]

Effect of a novel monoamine-oxidase inhibitor, moclobemide on the sensitivity to intravenous tyramine and norepinephrine in humans. [1991.05]

The effects of mood changes and antidepressants on the cognitive capacity of elderly depressed patients. [1989.09]

10-Hydroxynortriptyline and treatment effects in elderly depressed patients. [1989.03]

Other research related to Nardil (Phenelzine)

Phenelzine-induced myocardial injury: a case report. [2010.12]

The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats. [2007.11]

Acute myocarditis after massive phenelzine overdose. [2007.11]

Other possibly related research studies

Antidepressant-Associated Mood Elevations in Bipolar II Disorder Compared With Bipolar I Disorder and Major Depressive Disorder: A Systematic Review and Meta-Analysis. [2008.07.15]

Post-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies. [2007.08]

Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression. [2007.09]

Serotonin syndrome in elderly patients treated for psychotic depression with atypical antipsychotics and antidepressants: two case reports. [2007.08]

Treating DSM-IV depression with atypical features. [2007.04]

Translating the evidence on atypical depression into clinical practice. [2007]

Treating depression with atypical features. [2007]

Antidepressant therapy in tinnitus. [2007.04]

Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis. [2008.10]

Recent advances in understanding and treating social anxiety disorder. [2009.02]

Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. [2009.06]

[Irreversible, non-selective monoamine oxidase inhibitors] [2009.04.16]

Best practice guide for the treatment of nightmare disorder in adults. [2010.08.15]

Pharmacological interventions for borderline personality disorder. [2010.06.16]

Clinical Pharmacology Tyramine Challenge Study to Determine the Selectivity of the Monoamine Oxidase Type B (MAO-B) Inhibitor Rasagiline. [2010.05.05]

Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. [2010.02.15]

The alarm pheromone in male rats as a unique anxiety model: psychopharmacological evidence using anxiolytics. [2010.02]

Transport of phenylethylamine at intestinal epithelial (Caco-2) cells: mechanism and substrate specificity. [2010.02]

Interactions between herbal medicines and prescribed drugs: an updated systematic review. [2009]

Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials. [2011.04]

A systematic review of treatments for refractory depression in older people. [2011.07]

Best practice guide for the treatment of nightmare disorder in adults. [2010]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017